查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969081

血液淨化設備市場：按產品類型、模式、組件、通量、薄膜材質、最終用戶和應用分類的全球預測，2026年至2032年

Blood Purification Devices Market by Product Type, Modality, Component, Flux Rate, Membrane Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血液淨化設備市場價值將達到 170.4 億美元，到 2026 年將成長至 180.8 億美元，到 2032 年將達到 276.6 億美元，複合年成長率為 7.16%。

主要市場統計數據
基準年 2025 170.4億美元
預計年份：2026年 180.8億美元
預測年份 2032 276.6億美元
複合年成長率 (%) 7.16%

隨著臨床、商業和技術領域的發展趨勢重塑血液淨化設備及其在醫療保健中的作用，我們提供了觀點的分析。

血液淨化設備處於腎臟病學、重症監護和慢性病管理等關鍵且快速發展的領域的交匯點。日益複雜的臨床情況、膜化學和濾芯設計的進步，以及醫療服務模式逐漸分散化的趨勢，都重新定義了臨床醫生和醫療服務提供者開展體外循環和腹膜透析療法的方式。因此，設備製造商、醫院採購團隊和居家醫療提供者正在重新思考其產品系列、服務模式和臨床證據策略，以滿足患者需求，同時確保營運和監管合規性。

薄膜技術、數位化整合和分散式醫療保健的創新正在重新定義血液淨化設備的競爭格局和臨床路徑。

在材料科學、數位健康融合以及不斷演進的醫療服務模式的推動下，血液淨化領域正經歷著變革性的轉變。膜技術和吸附技術的創新提高了選擇性和動態穩定性，而模組化濾芯系統和一次性平台則簡化了臨床操作，並降低了交叉感染的風險。同時，製造商正在將感測器和數據分析技術融入血液淨化，以實現預測性維護、治療最佳化和遠端監測。這些進步拓展了血液淨化設備的效用，使其超越了傳統的治療管理範疇。

對 2025 年美國關稅措施對醫療設備製造商的供應鏈韌性、採購決策和定價動態的影響進行策略分析。

美國2025年實施的關稅措施對製造商、經銷商和醫療保健採購商產生了多層次的營運和策略影響。關稅壓力立即凸顯了計算全球供應鏈服務交付成本的重要性，促使許多公司重新評估其關鍵組件（例如薄膜、過濾器和精密加工零件）的籌資策略。因此，採購部門正在加快供應商合格審核，優先考慮雙重採購，並加強對到岸成本的審查，以確保獲利能力和供應的連續性。

將產品模式、臨床應用和組件策略與可行的產品組合和商業化優先事項進行整合細分洞察。

在血液淨化市場中，優先進行細分有助於明確臨床需求、商業性促進因素和創新之間的交集。根據產品類型，血液透析濾過 (HDF)、血液透析 (HD)、血液濾過 (HF)、血液灌流 (HP)、腹膜透析 (PD) 和血漿置換 (PA) 等治療方法各自具有不同的工程和臨床要求，這些要求會影響設備結構、一次性組件設計和臨床培訓需求。例如，專注於溶質清除的療法和專注於免疫調節的療法需要不同的膜特性和濾芯配置，這會影響製造的複雜性和售後服務模式。

區域市場動態將支付方框架、製造地和臨床應用趨勢連結起來，從而在世界各地創造了不同的機會。

區域趨勢持續影響全球企業發展的需求模式、監管複雜性和競爭格局。在美洲，成熟的支付方環境、居家科技的快速普及以及對臨床試驗和真實世界證據產生的大力投入，正在推動市場活躍。該地區的醫療服務提供者優先考慮與電子健康記錄、遠端監測和綜合護理路徑的整合，這推動了對能夠提供可衡量結果和簡化工作流程的設備的需求。

競爭考察和策略性企業級洞察突顯了產品組合擴展、售後市場策略和合作夥伴模式，這些都推動了差異化和規模化發展。

在血液淨化領域，競爭優勢越來越依賴產品組合的深度、售後市場的滲透率以及提供整合臨床解決方案的能力。主要企業意識到，過濾器、透析液組件和一次性產品是高頻需求和臨床偏好的主要促進因素，因此正在拓展業務範圍，超越固定資產，開發基於耗材和服務合約的永續收入來源。同時，各企業也在投資膜技術研發、用於客製化組件的積層製造技術以及嵌入式感測技術，以在性能和生命週期成本方面實現差異化競爭。

為確保血液淨化領域的韌性、擴大居家照護和建立永續的收入來源，製造商和供應商可採取的策略重點。

產業領導者需要採取有計劃、優先順序且分階段的步驟，以抓住市場機會並降低營運風險。首先，透過認證關鍵薄膜、過濾器和精密組件的多個來源，並探索本地組裝和近岸外包，實現供應鏈多元化，從而降低關稅風險並縮短前置作業時間。其次，加快開發家用和小型院內平台，將簡化的使用者介面與遠端醫療監測相結合，以擴大服務範圍並提高患者依從性。第三，優先投資於臨床證據的生成，以證明其在急性腎損傷、慢性腎臟病和膿毒症等關鍵適應症中的價值，並將醫療設備的性能與可衡量的結果聯繫起來，從而提供有助於與支付方談判的資訊。

採用嚴謹的混合調查方法，結合對臨床醫生的訪談、監管分析、供應鏈映射和實地觀察，以檢驗市場洞察。

本分析的調查方法整合了多方面的證據，以得出可靠且實用的見解。初步調查包括對醫療保健專業人員、採購負責人、醫療設備工程師以及製造和分銷機構的高級管理人員進行結構化訪談，以收集有關器械性能、服務期望和採購趨勢的第一手觀點。這些質性研究結果輔以對監管申報文件、臨床試驗註冊資訊和已發表文獻的系統性回顧，並對臨床適應症、安全性訊號和療效比較研究結果進行三角驗證。

對關鍵的臨床、商業性和供應鏈挑戰做出綜合性結論，從而為血液淨化設備領域實現永續競爭優勢指明方向。

總之，在材料科學進步、數位融合以及醫療模式轉向去中心化的推動下，血液淨化設備產業正處於轉折點。製造商和供應商面臨雙重挑戰：一方面要不斷創新以滿足不斷變化的臨床需求，另一方面要重組供應鏈和商業模式以應對地緣政治和貿易壓力。最成功的企業將使產品設計、臨床證據產生和售後服務與醫院、透析中心和居家照護機構的需求保持一致，從而創造出能夠同時引起支付方和臨床醫生共鳴的、具有競爭力的價值提案。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血液淨化設備市場：依產品類型分類

  • 血液透析濾過
  • 血液透析
  • 血液過濾
  • 血液灌注
  • 腹膜透析
  • 血漿置換療法

第9章：血液淨化設備市場：依模式分類

  • 家用
  • 設施內部

第10章 血液淨化設備市場：依組件分類

  • 透析液
  • 篩選
  • 裝置
  • 導管和套管

第11章 以通量率分類的血液淨化設備市場

  • 高通量
  • 低通量

第12章 按薄膜材料分類的血液淨化設備市場

  • 纖維素膜
  • 合成膜

第13章 血液淨化設備市場：依最終用戶分類

  • 透析中心
  • 居家醫療設施
  • 醫院

第14章 血液淨化設備市場：依應用領域分類

  • 急性腎損傷
  • 自體免疫疾病
  • 慢性腎臟病
  • 敗血症

第15章 血液淨化設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 血液淨化設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 血液淨化設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國血液淨化設備市場

第19章：中國血液淨化設備市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bellco SpA
  • Cerus Corporation
  • Cytosorbents Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Jafron Biomedical Co., Ltd.
  • Jafron Biomedical Co., Ltd.
  • Medtronic, Plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Terumo Corporation
  • Toray Industries, Inc.
Product Code: MRR-1A1A064C05FC

The Blood Purification Devices Market was valued at USD 17.04 billion in 2025 and is projected to grow to USD 18.08 billion in 2026, with a CAGR of 7.16%, reaching USD 27.66 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.04 billion
Estimated Year [2026] USD 18.08 billion
Forecast Year [2032] USD 27.66 billion
CAGR (%) 7.16%

An authoritative orientation to the clinical, commercial, and technological forces reshaping blood purification devices and their role across care settings

Blood purification devices occupy a critical and rapidly evolving intersection of nephrology, intensive care, and chronic disease management. Rising clinical complexity, advances in membrane chemistry and cartridge design, and progressive shifts toward decentralized care have collectively redefined how clinicians and providers approach extracorporeal and peritoneal therapies. As a result, device manufacturers, hospital procurement teams, and home-care providers are reassessing product portfolios, service models, and clinical evidence strategies to meet patient needs while maintaining operational and regulatory compliance.

Clinically, the drivers are clear: improvements in device biocompatibility and operational ease are enabling broader adoption across inpatient and outpatient settings, while digital connectivity and point-of-care monitoring are creating new expectations for interoperability and remote management. Economically, manufacturers must balance capital equipment sales with recurring revenue from consumables and maintenance contracts, and consequently are investing in lifecycle support and aftermarket services. In short, this market is characterized by technological progress, shifting care models, and intensifying focus on patient-centered outcomes, which together create both opportunity and urgency for strategic action.

How innovations in membranes, digital integration, and decentralized care are redefining competitive dynamics and clinical pathways for blood purification devices

The blood purification landscape has undergone transformative shifts driven by materials science, digital health integration, and evolving models of care delivery. Membrane innovations and adsorption technologies have improved selectivity and hemodynamic tolerance, while modular cartridge systems and single-use platforms have simplified point-of-care setup and reduced cross-contamination risk. Concurrently, manufacturers are incorporating sensors and data analytics to enable predictive maintenance, treatment optimization, and remote oversight, which together are elevating device utility beyond traditional therapy administration.

Additionally, care delivery is decentralizing as clinical stakeholders increasingly embrace home-based modalities and outpatient dialysis models to improve patient quality of life and reduce hospital strain. This trend has incentivized the design of compact, user-friendly machines and the development of telemonitoring solutions that support adherence and clinical supervision. Regulatory and reimbursement environments are also evolving to recognize value-based outcomes, prompting companies to place greater emphasis on real-world evidence generation and post-market surveillance. Taken together, these shifts are reshaping competitive dynamics, accelerating partnerships between device firms and digital health providers, and creating differentiated pathways for market entry and scale.

Strategic analysis of how 2025 United States tariff measures have reshaped supply chain resilience, sourcing decisions, and pricing dynamics for device manufacturers

The introduction of United States tariff measures in 2025 has produced a layered set of operational and strategic effects for manufacturers, distributors, and healthcare purchasers. Immediately, tariff pressure has amplified the importance of cost-to-serve calculations across global supply chains, prompting many firms to re-evaluate sourcing strategies for critical components such as membranes, filters, and precision-machined parts. Consequently, procurement teams have accelerated supplier qualification, prioritized dual-sourcing, and increased scrutiny of landed costs to preserve margin and ensure continuity of supply.

In response, several strategic pathways have emerged. Some manufacturers have pursued nearshoring and regional manufacturing hubs to mitigate tariff exposure and compress lead times, while others have invested in automation and process efficiencies to offset incremental import duties. Pricing strategies have become more dynamic, with greater use of contractual clauses that share cost fluctuations between suppliers and buyers. Regulatory compliance and documentation requirements have also intensified, as import tariffs often coincide with more stringent customs reviews and certification checks. Over the medium term, these shifts are likely to encourage vertical integration for critical consumables and accelerate the adoption of local assembly for higher-value systems. Importantly, successful actors will be those that combine tactical cost management with strategic investments in resilience, ensuring clinical supply stability without compromising product innovation.

Integrated segmentation insights that map product modalities, clinical applications, and component strategies to actionable portfolio and commercialization priorities

A segmentation-first view of the blood purification market clarifies where clinical need, commercial traction, and innovation converge. Based on product type, therapies such as hemodiafiltration, hemodialysis, hemofiltration, hemoperfusion, peritoneal dialysis, and plasmapheresis present distinct engineering and clinical requirements that influence device architecture, disposables design, and clinical training needs. For example, therapies focused on solute clearance versus immunomodulation demand different membrane properties and cartridge configurations, which in turn shape manufacturing complexity and aftermarket service models.

Based on end user, adoption patterns differ substantially between dialysis centers, home healthcare facilities, and hospitals; dialysis centers prioritize throughput and ergonomics, home healthcare requires compact footprints and simplified interfaces, and hospitals demand interoperability with critical care monitoring and rapid setup. Based on application, the clinical drivers vary from acute kidney injury and sepsis management to chronic kidney disease and autoimmune disorders, each creating specific performance specifications and evidence requirements. Based on modality, the distinction between home use and in-center determines packaging, remote monitoring capabilities, and training pathways. Based on component, value accrues differently across dialysate, filter, machine, and tubing & cannula, with consumables often underpinning recurring revenue and clinical preference. Based on flux rate, high flux and low flux products target separate clinical indications and influence membrane selection and clinical protocols. Finally, based on membrane material, choices between cellulosic membrane and synthetic membrane options affect biocompatibility, solute clearance profiles, and regulatory pathways. Understanding these intersecting segmentation axes enables targeted product positioning, differentiated pricing strategies, and prioritized investment in clinical evidence for the highest-impact subsegments.

Regional market dynamics that link payer frameworks, manufacturing footprints, and clinical adoption trends to differentiated opportunities across global territories

Regional dynamics continue to shape demand patterns, regulatory complexity, and competitive positioning across the global footprint. In the Americas, market activity is driven by a mature payer landscape, rapid adoption of home-use technologies, and strong investment in clinical trials and real-world evidence generation. Providers in the region emphasize integration with electronic health records, remote monitoring, and bundled care pathways, which fosters demand for devices that deliver measurable outcomes and streamlined workflows.

In Europe, the Middle East & Africa, regulatory heterogeneity and differences in public funding models produce a mosaic of opportunity and constraint. Procurement cycles may be longer and reimbursement pathways more centralized in some markets, while cross-border trade and regional distribution hubs enable specialized manufacturers to scale efficiently. In Asia-Pacific, demographic trends and rising incidence of chronic kidney conditions are driving demand growth alongside a rapidly expanding domestic manufacturing base. Local regulatory agencies are strengthening device oversight and fostering partnerships between multinational firms and regional producers to improve access and lower costs. Across all regions, supply chain resilience, local production capabilities, and tailored clinical support models determine competitive advantage and the speed at which innovations achieve clinical penetration.

Competitive and strategic company-level insights that highlight portfolio expansion, aftermarket strategies, and alliance models driving differentiation and scale

Competitive advantage in the blood purification arena increasingly stems from portfolio depth, aftermarket penetration, and the ability to deliver integrated clinical solutions. Leading firms are expanding beyond capital equipment to develop recurring revenue streams anchored in consumables and service contracts, recognizing that filters, dialysate components, and disposables drive high-frequency demand and clinical preference. At the same time, companies are investing in membrane R&D, additive manufacturing for customized components, and embedded sensing technology to differentiate on both performance and lifecycle cost.

Strategic collaboration is also prominent, with technology partnerships linking device manufacturers to digital health providers for telemonitoring and data analytics, and alliances with clinical centers to generate comparative effectiveness data. Mergers and alliances that enable vertical integration of key consumable supply chains or that broaden geographic reach are common strategic responses to tariff pressures and procurement consolidation. Ultimately, winners will combine clinical credibility, disciplined aftermarket execution, and nimble commercial models that address the distinct needs of hospitals, dialysis centers, and home-care providers.

Actionable strategic priorities for manufacturers and providers to secure resilience, expand home-based care, and build recurring revenue streams in blood purification

Industry leaders must act with deliberate, prioritized steps to capture market opportunities while mitigating operational risk. First, diversify supply chains by qualifying multiple sources for critical membranes, filters, and precision components, and by evaluating regional assembly or nearshoring to reduce tariff exposure and compress lead times. Second, accelerate development of home-use and compact in-center platforms that combine simplified user interfaces with telehealth-enabled monitoring to expand access and improve patient adherence. Third, prioritize investments in clinical evidence generation that demonstrate value in key applications such as acute kidney injury, chronic kidney disease, and sepsis, linking device performance to measurable outcomes that inform payer discussions.

In addition, adopt modular product architectures and standardized interfaces to reduce manufacturing complexity and enable faster product updates. Build predictable recurring revenue through consumables and maintenance services, and design flexible commercial agreements that reflect variable demand and cost pass-throughs. Finally, strengthen post-market surveillance and training programs to support safe adoption, and pursue partnerships with regional distributors and clinical networks to accelerate market entry. By combining these strategic moves, companies can preserve margin, enhance resilience, and position their offerings around clinical utility and total cost of care.

A rigorous mixed-methods research approach combining clinician interviews, regulatory analysis, supply chain mapping, and field observation to validate market insights

The research methodology underpinning this analysis synthesizes multiple evidence streams to produce robust, actionable insights. Primary research included structured interviews with clinicians, procurement officers, biomedical engineers, and senior executives from manufacturing and distribution organizations to capture frontline perspectives on device performance, service expectations, and procurement dynamics. These qualitative inputs were complemented by a systematic review of regulatory filings, clinical trial registries, and published literature to triangulate clinical indications, safety signals, and comparative effectiveness findings.

Supply chain mapping and patent landscape analysis were used to identify critical component dependencies and emerging technology trajectories, while targeted field visits to dialysis centers and home-care environments provided contextual understanding of workflow and patient experience. Throughout, data were cross-validated using multiple independent sources and expert review panels to minimize bias and improve reliability. Limitations include evolving regulatory developments and tariff policies that may shift rapidly; accordingly, the methodology includes scheduled update cycles and scenario analyses to reflect new information and maintain relevance for strategic decision-making.

Concluding synthesis of clinical, commercial, and supply chain imperatives that define the path to durable advantage in blood purification devices

In conclusion, the blood purification device sector is at an inflection point driven by material science advances, digital integration, and a clear migration toward decentralized care. Manufacturers and providers face a dual imperative: innovate to meet evolving clinical expectations while restructuring supply chains and commercial models to withstand geopolitical and trade pressures. The most successful organizations will align product design, clinical evidence generation, and aftermarket services to the needs of hospitals, dialysis centers, and home-care providers, thereby creating defensible value propositions that resonate with payers and clinicians alike.

Looking forward, strategic investments in membrane technology, telemonitoring, and regional manufacturing capacity will determine competitive positioning. By proactively addressing supply chain vulnerabilities, prioritizing modular, patient-centric designs, and committing to real-world evidence programs, stakeholders can convert current disruption into a durable advantage and improve patient access to advanced blood purification therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Purification Devices Market, by Product Type

  • 8.1. Hemodiafiltration
  • 8.2. Hemodialysis
  • 8.3. Hemofiltration
  • 8.4. Hemoperfusion
  • 8.5. Peritoneal Dialysis
  • 8.6. Plasmapheresis

9. Blood Purification Devices Market, by Modality

  • 9.1. Home Use
  • 9.2. In-Center

10. Blood Purification Devices Market, by Component

  • 10.1. Dialysate
  • 10.2. Filter
  • 10.3. Machine
  • 10.4. Tubing & Cannula

11. Blood Purification Devices Market, by Flux Rate

  • 11.1. High Flux
  • 11.2. Low Flux

12. Blood Purification Devices Market, by Membrane Material

  • 12.1. Cellulosic Membrane
  • 12.2. Synthetic Membrane

13. Blood Purification Devices Market, by End User

  • 13.1. Dialysis Center
  • 13.2. Home Healthcare Facilities
  • 13.3. Hospital

14. Blood Purification Devices Market, by Application

  • 14.1. Acute Kidney Injury
  • 14.2. Autoimmune Disorders
  • 14.3. Chronic Kidney Disease
  • 14.4. Sepsis

15. Blood Purification Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Blood Purification Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Blood Purification Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Blood Purification Devices Market

19. China Blood Purification Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Asahi Kasei Medical Co., Ltd.
  • 20.6. B. Braun Melsungen AG
  • 20.7. Baxter International Inc.
  • 20.8. Bellco S.p.A.
  • 20.9. Cerus Corporation
  • 20.10. Cytosorbents Corporation
  • 20.11. Fresenius Medical Care AG & Co. KGaA
  • 20.12. Jafron Biomedical Co., Ltd.
  • 20.13. Jafron Biomedical Co., Ltd.
  • 20.14. Medtronic, Plc
  • 20.15. Nikkiso Co., Ltd.
  • 20.16. Nipro Corporation
  • 20.17. Terumo Corporation
  • 20.18. Toray Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PURIFICATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PURIFICATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOPERFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOPERFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOPERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PLASMAPHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PLASMAPHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PLASMAPHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY IN-CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY IN-CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY IN-CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FILTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FILTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FILTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MACHINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MACHINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MACHINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY TUBING & CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY TUBING & CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY TUBING & CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HIGH FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HIGH FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HIGH FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY LOW FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY LOW FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY LOW FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CELLULOSIC MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CELLULOSIC MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CELLULOSIC MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SYNTHETIC MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SYNTHETIC MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SYNTHETIC MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSIS CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSIS CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSIS CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME HEALTHCARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME HEALTHCARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME HEALTHCARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY ACUTE KIDNEY INJURY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY ACUTE KIDNEY INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SEPSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SEPSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SEPSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 156. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 179. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 180. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 188. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)